Improve people's lives
Therapeutic areasFind out more
Contract ManufacturingFind out more
R&DFind out more
PatientsFind out more
Learn how we've been delivering on our mission for patients for 90 years.
ESTEVE REPORTS SIGNIFICANT GROWTH IN 2022 AND CONTINUES TO ADVANCE TOWARDS ITS VISION OF BECOMING AN INTERNATIONAL SPECIALTY PHARMA COMPANY
In 2022, the company has grown 15% in net revenues and has expanded its presence in Portugal and Italy.
To enable further growth and international expansion, ESTE...
ESTEVE BRINGS TO MARKET THE FIRST INHALED RESCUE TREATMENT DESIGNED TO CONTROL OFF EPISODES IN PARKINSON’S DISEASE¹
The company has obtained pricing and financing for an inhaled treatment for OFF periods in Parkinson's disease, which it launched on the Spanish market in mid-February 2023. ...
ESTEVE AND MEDTRONIC ARE COLLABORATING TO ADDRESS CANCER PAIN PATIENTS’ NEEDS
ESTEVE and MEDTRONIC have started an initiative to improve the pathway of patients with refractory cancer pain across Europe. Although most cancer sufferers respond well to co...